Catatan efek · kuartal yang diarsipkan
ASND
Ascendis Pharma A/S · Healthcare · Biotechnology
15Pemegang yang dilacak
0Δ pemegang
10.69MSaham yang dipegang
$2.13BNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -1.1% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +15 | 28.56M | $7.62B | +25 | −10 |
| Q1 2026 | 92 | -6 | 28.38M | $6.48B | +8 | −14 |
| Q4 2025 | 96 | -1 | 34.58M | $7.37B | — | −1 |
| Q3 2025 | 15 | 0 | 10.69M | $2.13B | +1 | −1 |
| Q2 2025 | 12 | -2 | 9.16M | $1.58B | — | −2 |
| Q1 2025 | 12 | +1 | 5.48M | $853.40M | +1 | — |
| Q4 2024 | 11 | -2 | 5.30M | $729.95M | — | −2 |
| Q3 2024 | 12 | +1 | 6.24M | $930.97M | +2 | −1 |
| Q2 2024 | 11 | — | 7.02M | $958.03M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.47M | -1.3% | $889.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.80M | +95.9% | $357.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.73M | -8.0% | $343.19M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 653.01K | — | $129.83M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 653.01K | — | $129.83M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 584.79K | — | $116.26M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 41 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 42 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 43 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 44 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | BlackRock ✦ (pasif) | 451.50K | -4.3% | $89.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 406.76K | — | $80.87M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Two Sigma Investments ✦ | 183.89K | +5803.2% | $36.56M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 56 | Millennium Management ✦ | 174.60K | +139.6% | $34.71M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Geode Capital Management ✦ (pasif) | 68.05K | +11.9% | $13.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 58 | State Street Global Advisors ✦ (pasif) | 61.54K | +5.7% | $12.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 59 | Arrowstreet Capital ✦ | 60.66K | Baru | $12.06M | 0.0% | New | 1 | SEC ↗ |
| 60 | Citadel Advisors ✦ | 27.64K | -95.3% | $5.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 61 | Citadel Advisors ✦ | 27.64K | -95.3% | $5.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 62 | Marshall Wace ✦ | 17.70K | -84.9% | $3.52M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 63 | Marshall Wace ✦ | 17.70K | -84.9% | $3.52M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 64 | D. E. Shaw & Co. ✦ | 3.59K | -50.1% | $712,933 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $12.06M | 0.0% |
Telah keluar
| Adage Capital Partners | $79.33M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 8 pemegang, 7.94M saham, $34.76M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Aug 14
BIENAIME JEAN JACQUES
Director · 1.10K lbr @ 245.85 · $270,435
Aug 14
BIENAIME JEAN JACQUES
Director · 900 lbr @ 246.91 · $222,219
Penjualan di pasar terbuka (S)
Tidak ada penjualan insider di pasar terbuka dalam jendela cakupan kami.
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi
Aug 13
SC 13G/A — Artisan Partners Limited Partnership
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API